Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · IEX Real-Time Price · USD
10.03
-0.19 (-1.86%)
At close: Jul 19, 2024, 4:00 PM
10.17
+0.14 (1.40%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Vir Biotechnology Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Vir Biotechnology stock have an average target of 34.14, with a low estimate of 12 and a high estimate of 110. The average target predicts an increase of 240.38% from the current stock price of 10.03.
Analyst Consensus: Buy
* Price targets were last updated on Jun 6, 2024.
Analyst Ratings
The average analyst rating for VIR stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $12 → $15 | Hold | Maintains | $12 → $15 | +49.55% | Jun 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +996.71% | Jun 5, 2024 |
| Needham | Needham | Strong Buy Maintains $15 → $19 | Strong Buy | Maintains | $15 → $19 | +89.43% | Jun 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +996.71% | May 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +996.71% | May 7, 2024 |
Financial Forecast
Revenue This Year
81.27M
from 86.18M
Decreased by -5.70%
Revenue Next Year
38.91M
from 81.27M
Decreased by -52.12%
EPS This Year
-3.42
from -4.59
EPS Next Year
-3.99
from -3.42
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 145.7M | 111.5M | 115.9M | 680.8M | 574.1M |
| Avg | 81.3M | 38.9M | 49.4M | 214.6M | 245.9M |
| Low | 55.3M | n/a | n/a | 39.2M | 39.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 69.1% | 37.2% | 197.9% | 1,278.8% | 167.5% |
| Avg | -5.7% | -52.1% | 26.9% | 334.6% | 14.6% |
| Low | -35.9% | - | - | -20.6% | -81.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.74 | -2.58 | -1.65 | -1.05 | -0.64 |
| Avg | -3.42 | -3.99 | -3.69 | -2.25 | -2.24 |
| Low | -3.95 | -5.49 | -6.17 | -3.92 | -3.75 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.